ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 226.8% in November

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 81,700 shares, a growth of 226.8% from the October 31st total of 25,000 shares. Based on an average daily trading volume, of 225,000 shares, the short-interest ratio is currently 0.4 days. Currently, 12.4% of the company’s stock are sold short.

ReShape Lifesciences Trading Down 1.6 %

RSLS traded down $0.09 during trading on Wednesday, hitting $5.59. The company had a trading volume of 18,549 shares, compared to its average volume of 99,127. ReShape Lifesciences has a one year low of $4.60 and a one year high of $34.22. The firm’s 50-day moving average price is $5.71 and its 200 day moving average price is $9.26.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.